GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation

News provided by

Sep 02, 2026, 08:00 ET

Recognizing exceptional leadership in patient education and clinical skill in the GammaTile procedure

TEMPE, Ariz., Sept. 2, 2026 /PRNewswire/ -- GT Medical Technologies, a company focused on improving the lives of patients with brain tumors, today announced Renown Regional Medical Center as the latest GammaTile^® Center of Excellence Program designation.

The program recognizes leaders in patient care dedicated to advancing brain tumor treatment. Physicians and their institutions who receive this designation have demonstrated an exceptional level of expertise in the GammaTile procedure by meeting specific clinical criteria, annual case minimums, and ongoing education requirements.

The following physicians are now recognized with achievement:

Suchit Patel, MD, PhD, Radiation Oncology
Garrett Green, MD, Radiation Oncology
Rima Rindler, MD, Neurosurgery
Angelique Tay, MD, Neurosurgery
Michael Moore, MD, Neurosurgery
Chris Demers, MD, Neurosurgery

"This is a significant milestone for our team and for the patients we serve," said Dr. Suchit Patel, Radiation Oncologist at Renown Regional Medical Center. "Integrating advanced treatments like GammaTile allows us to push the boundaries of care for complex brain tumors, while ensuring our community can access state-of-the-art medicine right here, close to home."

GammaTile is an innovative form of radiation therapy placed at the time of tumor removal surgery, delivering immediate, targeted radiation to the tumor site when cancer cells are at their lowest levels. Unlike conventional approaches, which often require a delay between surgery and radiation therapy to allow for wound healing, GammaTile eliminates this treatment gap. By delivering immediate, localized radiation directly at the tumor site, it is designed to maximize the treatment's effectiveness against remaining cancer cells and reduce the risk of regrowth.¹

About GT Medical Technologies, Inc.
GT Medical Technologies was founded by a dedicated team of tumor specialists to address unmet needs in brain tumor treatment. The Company is committed to improving the lives of patients with brain tumors through innovative solutions that elevate the standard of care. GammaTile is authorized for commercial distribution in the United States as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms.

About GammaTile
GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors. By delivering radiation directly from within—placed into the surgical cavity at the time of tumor removal—GammaTile provides immediate, localized treatment. This approach targets remaining cancer cells when they are at their lowest levels to help prevent regrowth, while minimizing radiation exposure to healthy brain tissue.

Since its full market launch in the United States in March 2020, GammaTile has been adopted by more than 100 leading centers, underscoring its growing acceptance in both academic and community healthcare settings. For more information, visit gammatile.com and follow @GammaTile on Facebook, Instagram, LinkedIn and X.

Media Contact:
Dawn Fallon
New Dawn Communications LLC
[email protected]
732-771-7808

References